PRLD icon

Prelude Therapeutics

60 hedge funds and large institutions have $113M invested in Prelude Therapeutics in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
+5
Holders Change %
+9.09%
% of All Funds
0.96%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
24
Reduced
16
Closed
2
Calls
$1K
Puts
$4K
Net Calls
-$3K
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
AB
51
Amalgamated Bank
New York
$3K
Legal & General Group
52
Legal & General Group
United Kingdom
$2.97K
AIP
53
Ameritas Investment Partners
Nebraska
$2.53K
Citigroup
54
Citigroup
New York
$1.63K -$10.2K -3,315 -86%
Deutsche Bank
55
Deutsche Bank
Germany
$1.38K +$1.38K +446 New
HWM
56
HighMark Wealth Management
Minnesota
$155
Nisa Investment Advisors
57
Nisa Investment Advisors
Missouri
$114 -$12.2K -3,963 -99%
UBS AM
58
UBS AM
Illinois
-$13M -2,273,894 Closed
Mirae Asset Global Investments
59
Mirae Asset Global Investments
South Korea
-$45.4K -10,087 Closed